BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2415279)

  • 1. Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome.
    Poli G; Introna M; Zanaboni F; Peri G; Carbonari M; Aiuti F; Lazzarin A; Moroni M; Mantovani A
    Clin Exp Immunol; 1985 Oct; 62(1):128-35. PubMed ID: 2415279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte function in intravenous drug abusers with lymphadenopathy syndrome and in patients with acquired immunodeficiency syndrome: selective impairment of chemotaxis.
    Poli G; Bottazzi B; Acero R; Bersani L; Rossi V; Introna M; Lazzarin A; Galli M; Mantovani A
    Clin Exp Immunol; 1985 Oct; 62(1):136-42. PubMed ID: 2998656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
    Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
    J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective natural cytotoxicity in patients with cancer: normal number of effector cells but decreased recycling capacity in patients with advanced disease.
    Steinhauer EH; Doyle AT; Reed J; Kadish AS
    J Immunol; 1982 Nov; 129(5):2255-9. PubMed ID: 7119445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
    Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
    J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of cytolytic activity by anti-T3 monoclonal antibody. Activation of alloimmune memory cells and natural killer cells from normal and immunodeficient individuals.
    Suthanthiran M; Williams PS; Solomon SD; Rubin AL; Stenzel KH
    J Clin Invest; 1984 Dec; 74(6):2263-71. PubMed ID: 6392343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased population of Leu-7+ natural killer cells in lymph nodes of homosexual men with AIDS-related persistent lymphadenopathy.
    Jothy S; Gilmore N; El'Gabalawy H; Prchal J
    Can Med Assoc J; 1985 Jan; 132(2):141-4. PubMed ID: 3965066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency of natural killer activity, but not of natural killer binding, in patients with lymphoadenopathy syndrome positive for antibodies to HTLV-III.
    Fontana L; Sirianni MC; de Sanctis G; Carbonari M; Ensoli B; Aiuti F
    Immunobiology; 1986 Jul; 171(4-5):425-35. PubMed ID: 3017846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
    Nair MP; Schwartz SA
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a nonoxidative mechanism of human natural killer (NK) cell cytotoxicity by using mononuclear effector cells from healthy donors and from patients with chronic granulomatous disease.
    Kay HD; Smith DL; Sullivan G; Mandell GL; Donowitz GR
    J Immunol; 1983 Oct; 131(4):1784-8. PubMed ID: 6311897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
    Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
    J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.